nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—CYP2E1—Parkinson's disease	0.798	1	CbGaD
Clonazepam—GABRB2—hindbrain—Parkinson's disease	0.00356	0.0526	CbGeAlD
Clonazepam—GABRA1—hindbrain—Parkinson's disease	0.00315	0.0465	CbGeAlD
Clonazepam—GABRB2—brainstem—Parkinson's disease	0.00204	0.0302	CbGeAlD
Clonazepam—GABRG2—forebrain—Parkinson's disease	0.00197	0.0291	CbGeAlD
Clonazepam—GABRB2—forebrain—Parkinson's disease	0.00197	0.0291	CbGeAlD
Clonazepam—TSPO—embryo—Parkinson's disease	0.00189	0.0278	CbGeAlD
Clonazepam—GABRA1—brainstem—Parkinson's disease	0.0018	0.0266	CbGeAlD
Clonazepam—GABRA1—forebrain—Parkinson's disease	0.00174	0.0257	CbGeAlD
Clonazepam—TSPO—brainstem—Parkinson's disease	0.00173	0.0255	CbGeAlD
Clonazepam—TSPO—forebrain—Parkinson's disease	0.00167	0.0246	CbGeAlD
Clonazepam—GABRG2—medulla oblongata—Parkinson's disease	0.00142	0.021	CbGeAlD
Clonazepam—GABRB2—medulla oblongata—Parkinson's disease	0.00142	0.021	CbGeAlD
Clonazepam—TSPO—cardiovascular system—Parkinson's disease	0.00141	0.0208	CbGeAlD
Clonazepam—GABRA3—head—Parkinson's disease	0.00138	0.0204	CbGeAlD
Clonazepam—GABRA3—nervous system—Parkinson's disease	0.00131	0.0194	CbGeAlD
Clonazepam—GABRB2—midbrain—Parkinson's disease	0.0013	0.0192	CbGeAlD
Clonazepam—GABRG2—midbrain—Parkinson's disease	0.0013	0.0192	CbGeAlD
Clonazepam—GABRB2—spinal cord—Parkinson's disease	0.00127	0.0187	CbGeAlD
Clonazepam—GABRG2—spinal cord—Parkinson's disease	0.00127	0.0187	CbGeAlD
Clonazepam—GABRA3—central nervous system—Parkinson's disease	0.00126	0.0187	CbGeAlD
Clonazepam—GABRA1—medulla oblongata—Parkinson's disease	0.00126	0.0186	CbGeAlD
Clonazepam—TSPO—medulla oblongata—Parkinson's disease	0.0012	0.0178	CbGeAlD
Clonazepam—GABRA1—midbrain—Parkinson's disease	0.00115	0.017	CbGeAlD
Clonazepam—GABRB2—head—Parkinson's disease	0.00113	0.0167	CbGeAlD
Clonazepam—GABRG2—head—Parkinson's disease	0.00113	0.0167	CbGeAlD
Clonazepam—GABRA1—spinal cord—Parkinson's disease	0.00112	0.0166	CbGeAlD
Clonazepam—TSPO—midbrain—Parkinson's disease	0.0011	0.0163	CbGeAlD
Clonazepam—TSPO—spinal cord—Parkinson's disease	0.00107	0.0159	CbGeAlD
Clonazepam—GABRG2—nervous system—Parkinson's disease	0.00107	0.0158	CbGeAlD
Clonazepam—GABRB2—nervous system—Parkinson's disease	0.00107	0.0158	CbGeAlD
Clonazepam—GABRB2—central nervous system—Parkinson's disease	0.00103	0.0152	CbGeAlD
Clonazepam—GABRG2—central nervous system—Parkinson's disease	0.00103	0.0152	CbGeAlD
Clonazepam—GABRB2—cerebellum—Parkinson's disease	0.00101	0.0149	CbGeAlD
Clonazepam—GABRG2—cerebellum—Parkinson's disease	0.00101	0.0149	CbGeAlD
Clonazepam—GABRA3—brain—Parkinson's disease	0.001	0.0148	CbGeAlD
Clonazepam—GABRA1—head—Parkinson's disease	0.000997	0.0147	CbGeAlD
Clonazepam—TSPO—head—Parkinson's disease	0.000955	0.0141	CbGeAlD
Clonazepam—GABRA1—nervous system—Parkinson's disease	0.000945	0.014	CbGeAlD
Clonazepam—GABRA1—central nervous system—Parkinson's disease	0.00091	0.0134	CbGeAlD
Clonazepam—TSPO—nervous system—Parkinson's disease	0.000905	0.0134	CbGeAlD
Clonazepam—GABRA1—cerebellum—Parkinson's disease	0.000889	0.0131	CbGeAlD
Clonazepam—TSPO—central nervous system—Parkinson's disease	0.000871	0.0129	CbGeAlD
Clonazepam—TSPO—cerebellum—Parkinson's disease	0.000852	0.0126	CbGeAlD
Clonazepam—GABRG2—brain—Parkinson's disease	0.000818	0.0121	CbGeAlD
Clonazepam—GABRB2—brain—Parkinson's disease	0.000818	0.0121	CbGeAlD
Clonazepam—CYP2E1—cardiovascular system—Parkinson's disease	0.000814	0.012	CbGeAlD
Clonazepam—GABRA1—brain—Parkinson's disease	0.000722	0.0107	CbGeAlD
Clonazepam—CYP2E1—medulla oblongata—Parkinson's disease	0.000696	0.0103	CbGeAlD
Clonazepam—TSPO—brain—Parkinson's disease	0.000692	0.0102	CbGeAlD
Clonazepam—ALB—brain—Parkinson's disease	0.000676	0.00997	CbGeAlD
Clonazepam—CYP2E1—spinal cord—Parkinson's disease	0.00062	0.00916	CbGeAlD
Clonazepam—Bromazepam—CYP2E1—Parkinson's disease	0.000558	0.1	CrCbGaD
Clonazepam—CYP2E1—head—Parkinson's disease	0.000551	0.00814	CbGeAlD
Clonazepam—CYP2E1—nervous system—Parkinson's disease	0.000523	0.00772	CbGeAlD
Clonazepam—CYP2E1—central nervous system—Parkinson's disease	0.000503	0.00743	CbGeAlD
Clonazepam—CYP2E1—cerebellum—Parkinson's disease	0.000492	0.00726	CbGeAlD
Clonazepam—Clozapine—HTR7—Parkinson's disease	0.000422	0.0758	CrCbGaD
Clonazepam—CYP3A4—nervous system—Parkinson's disease	0.000421	0.00621	CbGeAlD
Clonazepam—Flunitrazepam—CYP2E1—Parkinson's disease	0.00042	0.0754	CrCbGaD
Clonazepam—CYP3A4—central nervous system—Parkinson's disease	0.000405	0.00598	CbGeAlD
Clonazepam—CYP2E1—brain—Parkinson's disease	0.0004	0.0059	CbGeAlD
Clonazepam—Clozapine—DRD3—Parkinson's disease	0.000397	0.0713	CrCbGaD
Clonazepam—Clozapine—DRD1—Parkinson's disease	0.00039	0.07	CrCbGaD
Clonazepam—Nitrazepam—CYP2E1—Parkinson's disease	0.000379	0.0681	CrCbGaD
Clonazepam—Flurazepam—CYP2E1—Parkinson's disease	0.000337	0.0605	CrCbGaD
Clonazepam—Clozapine—HTR1A—Parkinson's disease	0.000324	0.0581	CrCbGaD
Clonazepam—Midazolam—CYP2E1—Parkinson's disease	0.000313	0.0561	CrCbGaD
Clonazepam—Clozapine—DRD2—Parkinson's disease	0.000275	0.0493	CrCbGaD
Clonazepam—Diazepam—CYP2E1—Parkinson's disease	0.000268	0.0481	CrCbGaD
Clonazepam—Clozapine—CYP2E1—Parkinson's disease	0.000264	0.0475	CrCbGaD
Clonazepam—Clozapine—HTR2A—Parkinson's disease	0.000212	0.0381	CrCbGaD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000206	0.0016	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000205	0.00159	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000205	0.00159	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—HSPA8—Parkinson's disease	0.000204	0.00158	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000203	0.00158	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000202	0.00157	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—DLG4—Parkinson's disease	0.000201	0.00156	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.0002	0.00156	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0002	0.00155	CbGpPWpGaD
Clonazepam—Nitrazepam—ABCB1—Parkinson's disease	0.000199	0.0357	CrCbGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	0.000199	0.00154	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—IGF2—Parkinson's disease	0.000198	0.00154	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000196	0.00152	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—GRIN2B—Parkinson's disease	0.000196	0.00152	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—HSPA8—Parkinson's disease	0.000196	0.00152	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000195	0.00151	CbGpPWpGaD
Clonazepam—Clozapine—CYP2D6—Parkinson's disease	0.000194	0.0349	CrCbGaD
Clonazepam—GABRB2—Neuronal System—SLC6A3—Parkinson's disease	0.000193	0.0015	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.000193	0.0015	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—MTHFR—Parkinson's disease	0.000193	0.0015	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—DLG4—Parkinson's disease	0.000191	0.00149	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	0.000189	0.00146	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—INS—Parkinson's disease	0.000188	0.00146	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	0.000187	0.00145	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—HGF—Parkinson's disease	0.000187	0.00145	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000187	0.00145	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PLA2G6—Parkinson's disease	0.000186	0.00145	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—MAOB—Parkinson's disease	0.000185	0.00143	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	0.000184	0.00143	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000184	0.00142	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000183	0.00142	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000181	0.0014	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.000179	0.00139	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	0.000178	0.00138	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000178	0.00138	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MERTK—Parkinson's disease	0.000177	0.00137	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—DOCK3—Parkinson's disease	0.000177	0.00137	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.000177	0.00137	CbGpPWpGaD
Clonazepam—Flurazepam—ABCB1—Parkinson's disease	0.000177	0.0317	CrCbGaD
Clonazepam—ALB—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.000174	0.00135	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000172	0.00133	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000171	0.00133	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00017	0.00132	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	0.00017	0.00132	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000169	0.00131	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000168	0.0013	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000168	0.0013	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.000166	0.00129	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000165	0.00128	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000164	0.00128	CbGpPWpGaD
Clonazepam—Midazolam—ABCB1—Parkinson's disease	0.000164	0.0294	CrCbGaD
Clonazepam—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000163	0.00127	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.00016	0.00125	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000159	0.00123	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—DGKQ—Parkinson's disease	0.000158	0.00123	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000157	0.00122	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000157	0.00122	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000156	0.00121	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000155	0.0012	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—INS—Parkinson's disease	0.000153	0.00119	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.000153	0.00119	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000151	0.00117	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—COMT—Parkinson's disease	0.00015	0.00117	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000149	0.00116	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000149	0.00115	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000146	0.00113	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000145	0.00113	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000143	0.00111	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.000141	0.00109	CbGpPWpGaD
Clonazepam—Diazepam—ABCB1—Parkinson's disease	0.00014	0.0252	CrCbGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000139	0.00108	CbGpPWpGaD
Clonazepam—Clozapine—ABCB1—Parkinson's disease	0.000139	0.0249	CrCbGaD
Clonazepam—NAT2—Metabolism—CYP2D6—Parkinson's disease	0.000137	0.00106	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000137	0.00106	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000137	0.00106	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000136	0.00105	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CTGF—Parkinson's disease	0.000135	0.00105	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000133	0.00104	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000131	0.00102	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000131	0.00102	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.00013	0.00101	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—COMT—Parkinson's disease	0.000129	0.001	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	0.000128	0.000995	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	0.000128	0.000993	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	0.000127	0.000986	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000127	0.000983	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000127	0.000982	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP2E1—Parkinson's disease	0.000125	0.000974	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.000124	0.000966	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NQO1—Parkinson's disease	0.000124	0.000963	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—TH—Parkinson's disease	0.000122	0.000949	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000122	0.000949	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.000122	0.000945	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000119	0.000924	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	0.000118	0.000915	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000117	0.000912	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYCS—Parkinson's disease	0.000117	0.000911	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000117	0.000905	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000116	0.000902	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.000114	0.000887	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000112	0.000867	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000106	0.000824	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—COMT—Parkinson's disease	0.000104	0.000807	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000104	0.000807	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTP1—Parkinson's disease	0.000103	0.000803	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—MAOA—Parkinson's disease	0.000103	0.000801	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—HMOX1—Parkinson's disease	0.000102	0.000792	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000102	0.000791	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MAG—Parkinson's disease	0.000102	0.00079	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.0001	0.000779	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.0001	0.000777	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.98e-05	0.000774	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.92e-05	0.000769	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ABCB1—Parkinson's disease	9.8e-05	0.00076	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.52e-05	0.000739	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTM1—Parkinson's disease	9.51e-05	0.000738	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	9.51e-05	0.000738	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	9.36e-05	0.000726	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	9.24e-05	0.000717	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.13e-05	0.000708	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GPX1—Parkinson's disease	9.11e-05	0.000707	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	9.08e-05	0.000705	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	8.78e-05	0.000681	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.68e-05	0.000673	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—MTHFR—Parkinson's disease	8.4e-05	0.000652	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MCCC1—Parkinson's disease	8.36e-05	0.000649	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ND3—Parkinson's disease	8.36e-05	0.000649	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.33e-05	0.000646	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.31e-05	0.000645	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TNF—Parkinson's disease	8.3e-05	0.000644	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	8.29e-05	0.000643	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.28e-05	0.000642	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	8.23e-05	0.000639	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.98e-05	0.000619	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.94e-05	0.000616	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.93e-05	0.000616	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	7.89e-05	0.000612	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TALDO1—Parkinson's disease	7.86e-05	0.00061	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—OMD—Parkinson's disease	7.86e-05	0.00061	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—APOE—Parkinson's disease	7.82e-05	0.000607	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.78e-05	0.000604	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.63e-05	0.000592	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.62e-05	0.000591	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	7.45e-05	0.000578	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.28e-05	0.000565	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	7.25e-05	0.000563	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	7.22e-05	0.00056	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MCCC1—Parkinson's disease	7.18e-05	0.000557	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ND3—Parkinson's disease	7.18e-05	0.000557	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.12e-05	0.000552	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GCH1—Parkinson's disease	7.11e-05	0.000551	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.94e-05	0.000538	CbGpPWpGaD
Clonazepam—ALB—Metabolism—OMD—Parkinson's disease	6.75e-05	0.000524	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TALDO1—Parkinson's disease	6.75e-05	0.000524	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL6—Parkinson's disease	6.7e-05	0.00052	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—INS—Parkinson's disease	6.68e-05	0.000519	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	6.68e-05	0.000518	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.66e-05	0.000517	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	6.59e-05	0.000511	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—FGB—Parkinson's disease	6.42e-05	0.000498	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NDUFB11—Parkinson's disease	6.4e-05	0.000497	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GBA—Parkinson's disease	6.33e-05	0.000492	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—DBH—Parkinson's disease	6.33e-05	0.000492	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—FBP1—Parkinson's disease	6.33e-05	0.000492	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GCH1—Parkinson's disease	6.11e-05	0.000474	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.98e-05	0.000464	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.95e-05	0.000462	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.94e-05	0.000461	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.9e-05	0.000458	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.88e-05	0.000456	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.87e-05	0.000455	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.51e-05	0.000428	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.47e-05	0.000424	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GBA—Parkinson's disease	5.44e-05	0.000422	CbGpPWpGaD
Clonazepam—ALB—Metabolism—FBP1—Parkinson's disease	5.44e-05	0.000422	CbGpPWpGaD
Clonazepam—ALB—Metabolism—DBH—Parkinson's disease	5.44e-05	0.000422	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.39e-05	0.000419	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	5.32e-05	0.000413	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SOD1—Parkinson's disease	4.76e-05	0.00037	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.76e-05	0.000369	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—DDC—Parkinson's disease	4.65e-05	0.000361	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.57e-05	0.000354	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ABL1—Parkinson's disease	4.55e-05	0.000353	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IGF2—Parkinson's disease	4.53e-05	0.000351	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTA4—Parkinson's disease	4.39e-05	0.000341	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HGF—Parkinson's disease	4.27e-05	0.000332	CbGpPWpGaD
Clonazepam—ALB—Metabolism—DDC—Parkinson's disease	4e-05	0.00031	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.97e-05	0.000308	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	3.95e-05	0.000307	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MAOB—Parkinson's disease	3.91e-05	0.000304	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ND3—Parkinson's disease	3.88e-05	0.000301	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.88e-05	0.000301	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.81e-05	0.000296	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTA4—Parkinson's disease	3.77e-05	0.000293	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.73e-05	0.000289	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.65e-05	0.000283	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—OMD—Parkinson's disease	3.65e-05	0.000283	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.46e-05	0.000268	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PLA2G6—Parkinson's disease	3.4e-05	0.000264	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MAOB—Parkinson's disease	3.36e-05	0.000261	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.3e-05	0.000256	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.2e-05	0.000248	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GBA—Parkinson's disease	2.94e-05	0.000228	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—DBH—Parkinson's disease	2.94e-05	0.000228	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.94e-05	0.000228	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	2.91e-05	0.000226	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CTGF—Parkinson's disease	2.85e-05	0.000222	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NQO1—Parkinson's disease	2.63e-05	0.000204	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TH—Parkinson's disease	2.59e-05	0.000201	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP2D6—Parkinson's disease	2.5e-05	0.000194	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYCS—Parkinson's disease	2.49e-05	0.000193	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CTGF—Parkinson's disease	2.45e-05	0.00019	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP2E1—Parkinson's disease	2.29e-05	0.000177	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NQO1—Parkinson's disease	2.26e-05	0.000175	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TH—Parkinson's disease	2.23e-05	0.000173	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—COMT—Parkinson's disease	2.2e-05	0.000171	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTP1—Parkinson's disease	2.19e-05	0.00017	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MAOA—Parkinson's disease	2.19e-05	0.00017	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HMOX1—Parkinson's disease	2.16e-05	0.000168	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—DDC—Parkinson's disease	2.16e-05	0.000167	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYCS—Parkinson's disease	2.14e-05	0.000166	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ABCB1—Parkinson's disease	2.08e-05	0.000161	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.04e-05	0.000158	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTM1—Parkinson's disease	2.02e-05	0.000156	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.93e-05	0.00015	CbGpPWpGaD
Clonazepam—ALB—Metabolism—COMT—Parkinson's disease	1.89e-05	0.000147	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTP1—Parkinson's disease	1.89e-05	0.000146	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MAOA—Parkinson's disease	1.88e-05	0.000146	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HMOX1—Parkinson's disease	1.86e-05	0.000144	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.83e-05	0.000142	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.82e-05	0.000141	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ABCB1—Parkinson's disease	1.78e-05	0.000138	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.78e-05	0.000138	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTM1—Parkinson's disease	1.73e-05	0.000134	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GPX1—Parkinson's disease	1.66e-05	0.000129	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—APOE—Parkinson's disease	1.66e-05	0.000129	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MTHFR—Parkinson's disease	1.53e-05	0.000119	CbGpPWpGaD
Clonazepam—ALB—Metabolism—APOE—Parkinson's disease	1.43e-05	0.000111	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—INS—Parkinson's disease	1.42e-05	0.00011	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.35e-05	0.000105	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.32e-05	0.000103	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.23e-05	9.58e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.22e-05	9.47e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—INS—Parkinson's disease	1.22e-05	9.45e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TH—Parkinson's disease	1.2e-05	9.33e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.15e-05	8.96e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—COMT—Parkinson's disease	1.02e-05	7.94e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.02e-05	7.9e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.02e-05	7.88e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1e-05	7.79e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	9.63e-06	7.48e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	9.35e-06	7.26e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.96e-06	6.95e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	8.27e-06	6.41e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—APOE—Parkinson's disease	7.7e-06	5.97e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—INS—Parkinson's disease	6.57e-06	5.1e-05	CbGpPWpGaD
